Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Unlock with PBS Passport
55:40
Ruti Teitel; Aria Florant; Jonathan Freedland; Kate Shaw
Unlock with PBS Passport
55:50
Stefano Pozzebon; Leopoldo López; Shannon Heffernan; Julieta Martinelli; Susan Glasser
Unlock with PBS Passport
55:50
David Dimbleby; Kiran Desai; Zaynab Mohamed
Unlock with PBS Passport
55:43
Celeste Wallander; Peter Frankopan; Mohammed bin Abdulrahman al-Thani; Kaja Kallas; David Remnick
Unlock with PBS Passport
55:50
Ahmed Al-Sharaa; Clare Sebastian; Demetre Daskalakis
Unlock with PBS Passport
55:28
Rupert Smith; Annie Lebovitz; Will Sommer
Unlock with PBS Passport
55:48
Ivan Duque; Farnaz Fassihi; Joshua Yaffa
Unlock with PBS Passport
55:45
Julianne Smith; Ehud Olmert; Sen. Bill Cassidy
Unlock with PBS Passport
55:51
Yaroslav Trofimov; Andrey Kurkov; Steve Hartman; Bryan Muehlberger, Mahnaz Afkhami
Unlock with PBS Passport
55:50
Stephen Collinson; Brian Winter; John Kerry; Pastor Tim Johnson; Andrew Rice
Unlock with PBS Passport
55:46
Daniel Kurtzer; Jordan Thomas; Kelsey Grammer
Unlock with PBS Passport
55:48
Philippe Lazzarini; Lawrence Wright; Dr. Jonathan Metzl